Anti-C3 antibody [11H9]
4
(4 Reviews)
|
(107 Publications)
Anti-C3 antibody [11H9] (ab11862) is a rat monoclonal antibody detecting C3/C3b in ICC/IF. Suitable for Mouse.
- Over 50 publications
- Trusted since 2004
View Alternative Names
Complement C3, HSE-MSF, C3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-C3 antibody [11H9] (AB11862)
ab11862 staining C3 in murine kidney cells by Immunocytochemistry/ Immunofluorescence.C3 protein fragments deposited on kidney cells of MPL-lpr mouse. Glomerular staining pattern.
- WB
CiteAb
Western blot - Anti-C3 antibody [11H9] (AB11862)
Western Blotting using Anti-C3 antibody [11H9], ab11862. Publication image from Zhang, B. et al., 2017, Acta Neuropathol, 28612290. Legend direct from paper.
A decrease in TYROBP protein decreases oligomeric Aβ levels and alters phospho-TAU, synaptophysin, LAMP1, and complement C3 levels in 4-month-old APP/PSEN1 mice. a–c Hemibrains of male and female APP/PSEN1 (n = 4–6), APP/PSEN1; Tyrobp+/− (n = 3–8) and APP/PSEN1; Tyrobp−/− (n = 3–4) mice were processed via differential detergent solubilization to produce fractions of TBS soluble, Triton-X soluble, and formic acid soluble Aβ. Oligomeric Aβ was assessed from the TBS-soluble fraction via dot blot analyses using NU-4 (a), A11 (b) and OC (c) antibodies. d–i Western blot analysis in brain protein homogenates from 4-month-old male and female mice WT, Tyrobp+/−, Tyrobp−/− and APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. d, e Phospho-tau (AT8 epitope)/total tau ratio for dWT, Tyrobp+/−, Tyrobp−/− mice and eAPP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. f, g Synaptophysin level for fWT, Tyrobp+/−, Tyrobp−/− mice and gAPP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. h Marker of dystrophic neurites (Lamp1) in APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. i Complement C3 in APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. At least two independent western blot analyses were performed. Representative immunoreactive bands from the same western blot are shown on the right. n = 3–6 mice per group. Two-way ANOVA corrected for multiple comparisons (Tukey) was used for all statistical comparisons in male and female mice, *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. Data presented as mean ± SEM
false
Reactivity data
Product details
Anti-C3 antibody [11H9] (ab11862) is a rat monoclonal antibody and is validated for use in Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse samples.
Trusted by the scientific community
Anti-C3 [11H9] (ab11862) was first used in a scientific publication in 2004 and has been cited over 50 times in peer-reviewed journals.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Complement component C3 forms part of the innate immune system by promoting opsonization which enhances phagocytosis of pathogens. C3b binds to pathogens' surfaces facilitating their recognition by phagocytes. C3 as part of a complex with C3 convertase also has a role in amplifying the activation of the complement cascade. The proteolytic cleavage of C3 into C3b and C3a leads to the activation of other components forming the membrane attack complex and orchestrating inflammation.
Pathways
The complement component C3 functions within both the classical and alternative complement pathways. It acts as a convergence point where the complement activation pathways meet. C3 is activated into C3b and C3a which are key to amplifying the cascade. Furthermore C3 interacts with proteins such as factor B and factor D in the alternative pathway and C4 and C2 in the classical pathway facilitating the formation of C3 convertase necessary for pathway progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (107)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 8:1446 PubMed41068254
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 647:498-505 PubMed40931063
2025
Applications
Unspecified application
Species
Unspecified reactive species
Haematologica : PubMed40820810
2025
Applications
Unspecified application
Species
Unspecified reactive species
IBRO neuroscience reports 19:300-306 PubMed40747365
2025
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 10:28446-28465 PubMed40657111
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:320 PubMed40651955
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 18:8579-8592 PubMed40620607
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC microbiology 25:412 PubMed40615777
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 22:69 PubMed40055743
2025
Applications
Unspecified application
Species
Unspecified reactive species
mSystems 10:e0154024 PubMed40008883
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com